International Congress Munich 2014

---

From bench to bedside: biomarkers and biobanking for lung cancer in 2014

Symposium
Chairs: P. Bonniaud (Dijon, France), P. Schnabel (Meckesheim, Germany)
Aims: The aims of this symposium are to:
- Give insights into tissue banking principles and practices;
- Describe pitfalls in translational research methodology;
- Give examples of the successful development of biomarkers for early lung cancer detection and lung cancer prognosis; and,
- Describe the legal regulations regarding biobanking in the EU.

Biomarkers for non-small cell lung cancer (NSCLC) treatment: examples and unmet needs, a clinical perspective J-P. Sculier (Brussels, Belgium)
Quantitative prognostic markers for NSCLC: the state-of-the-art and methodology M. Skrzypski (Sopot, Poland)